223 related articles for article (PubMed ID: 20014684)
1. The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.
Wright WL
Adv Nurse Pract; 2009 Nov; 17(11):suppl 1-16. PubMed ID: 20014684
[No Abstract] [Full Text] [Related]
2. Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review.
Elkeles RS
Diabet Med; 2014 Jul; 31(7):880. PubMed ID: 24588426
[No Abstract] [Full Text] [Related]
3. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
Fonseca VA; Rosenstock J; Wang AC; Truitt KE; Jones MR
Diabetes Care; 2008 Aug; 31(8):1479-84. PubMed ID: 18458145
[TBL] [Abstract][Full Text] [Related]
4. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
Handelsman Y
Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
[TBL] [Abstract][Full Text] [Related]
5. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
Marrs JC
Drugs Aging; 2012 May; 29(5):e1-e12. PubMed ID: 22530704
[TBL] [Abstract][Full Text] [Related]
6. Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review.
Ooi CP; Loke SC
Diabet Med; 2014 Jan; 31(1):2-14. PubMed ID: 24024701
[TBL] [Abstract][Full Text] [Related]
7. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of colesevelam on lowering glycemia and lipids.
Aggarwal S; Loomba RS; Arora RR
J Cardiovasc Pharmacol; 2012 Feb; 59(2):198-205. PubMed ID: 21983746
[TBL] [Abstract][Full Text] [Related]
9. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
Bays HE
Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
[TBL] [Abstract][Full Text] [Related]
10. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
Jialal I; Abby SL; Misir S; Nagendran S
Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
12. Colesevelam for the management of type 2 diabetes.
Marrs JC
Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):187-94. PubMed ID: 19239397
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
Gavin JR; Jones MR; Ford DM; Truitt KE
Drugs Aging; 2014 Jun; 31(6):461-70. PubMed ID: 24777691
[TBL] [Abstract][Full Text] [Related]
14. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
[TBL] [Abstract][Full Text] [Related]
15. Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
Rosenson RS; Abby SL; Jones MR
Atherosclerosis; 2009 Jun; 204(2):342-4. PubMed ID: 18996525
[TBL] [Abstract][Full Text] [Related]
16. The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.
Goldfine AB; Fonseca VA
Postgrad Med; 2009 May; 121(3 Suppl 1):13-8. PubMed ID: 19494473
[TBL] [Abstract][Full Text] [Related]
17. A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL.
Goldberg RB
Curr Diab Rep; 2009 Oct; 9(5):331-2. PubMed ID: 19793501
[No Abstract] [Full Text] [Related]
18. Sevelamer in a diabetologist's perspective: a phosphate-binding resin with glucose-lowering potential.
Brønden A; Hansen M; Sonne DP; Rohde U; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2015 Feb; 17(2):116-20. PubMed ID: 25041567
[TBL] [Abstract][Full Text] [Related]
19. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
Bays HE; Goldberg RB; Truitt KE; Jones MR
Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
[TBL] [Abstract][Full Text] [Related]
20. The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.
Handelsman Y
Postgrad Med; 2009 May; 121(3 Suppl 1):5-6. PubMed ID: 19494471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
